A detailed history of Cfs Investment Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cfs Investment Advisory Services, LLC holds 24,641 shares of ABBV stock, worth $4.32 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
24,641
Previous 24,569 0.29%
Holding current value
$4.32 Million
Previous $4.21 Million 15.47%
% of portfolio
0.41%
Previous 0.34%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $11,796 - $14,351
72 Added 0.29%
24,641 $4.87 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $163,303 - $190,701
-1,055 Reduced 4.12%
24,569 $4.21 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $14,863 - $16,935
-93 Reduced 0.36%
25,624 $4.67 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $152,323 - $171,551
-1,107 Reduced 4.13%
25,717 $3.99 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $672,358 - $778,353
5,033 Added 23.1%
26,824 $4 Million
Q2 2023

Jul 21, 2023

SELL
$132.51 - $164.9 $199,957 - $248,834
-1,509 Reduced 6.48%
21,791 $2.94 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $308,742 - $355,562
2,135 Added 10.09%
23,300 $3.71 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $380,905 - $456,805
2,754 Added 14.96%
21,165 $3.42 Million
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $329 Million - $378 Million
-2,452,529 Reduced 99.25%
18,411 $2.47 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $329 Million - $377 Million
2,452,285 Added 13145.46%
2,470,940 $18,000
Q2 2022

Aug 16, 2022

SELL
$137.62 - $174.96 $417 Million - $530 Million
-3,027,554 Reduced 99.39%
18,655 $2.86 Million
Q1 2022

May 27, 2022

BUY
$131.98 - $163.75 $400 Million - $496 Million
3,027,814 Added 16459.98%
3,046,209 $19,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $109,256 - $138,240
-1,017 Reduced 5.24%
18,395 $2.52 Million
Q3 2021

Nov 19, 2021

BUY
$106.4 - $120.78 $2.07 Million - $2.34 Million
19,412 New
19,412 $2.09 Million
Q2 2021

Jul 21, 2021

SELL
$105.21 - $117.21 $2.12 Million - $2.36 Million
-20,135 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $1.62 Million - $2.19 Million
20,135 New
20,135 $2.16 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cfs Investment Advisory Services, LLC Portfolio

Follow Cfs Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfs Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfs Investment Advisory Services, LLC with notifications on news.